Search
Search Results
-
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
BackgroundMultiple sclerosis (MS) is a chronic, autoimmune, and inflammatory disease. The economic burden of MS is substantial, and the high cost of...
-
Stochastic cost-effectiveness analysis on population benefits
Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have...
-
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer
BackgroundTamoxifen (TAM) is recommended as the first-line strategy for men with estrogen receptor (ER)-positive early breast cancer who are...
-
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
The use of multiple cost-effectiveness thresholds in pharmacoeconomic evaluation is a hotly debated topic in the international academic community....
-
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
BackgroundThe escalating prevalence of type 2 diabetes (T2DM) poses an unparalleled economic catastrophe to develo** countries. Cardiovascular...
-
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review
Background and ObjectiveDeep brain stimulation (DBS) is an established treatment for Parkinson’s disease (PD) in patients with advanced motor...
-
The cost-effectiveness of school-based interventions for chronic diseases: a systematic review
BackgroundChronic diseases, or non-communicable diseases (NCD), are conditions of long duration and often influenced and contributed by complex...
-
Cost analysis and cost effectiveness of a subsidized community supported agriculture intervention for low-income families
BackgroundThe food system has a dynamic influence on disparities in food security and diet-related chronic disease. Community supported agriculture...
-
Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
BackgroundWhile the efficacy and safety of zanubrutinib have been established in relapsed or refractory chronic lymphocytic leukemia, the evidence on...
-
Cost-effectiveness analysis of metformin versus insulin in the treatment of gestational diabetes mellitus
ObjectiveAlthough there have been many studies on gestational diabetes mellitus (GDM) treatment, there is still a knowledge gap regarding the...
-
Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case
Artificial intelligence (AI) models have shown great accuracy in health screening. However, for real-world implementation, high accuracy may not...
-
Serum and 24-hour urinary tests cost-effectiveness in stone formers
ObjectiveTo assess the routine serum and 24-hour urine tests proficiency in diagnosing the baseline metabolic abnormality of kidney stone formers.
...
-
Cost-effectiveness analysis of nivolumab versus placebo for relapsed malignant mesothelioma
BackgroundAlthough nivolumab has shown clinical benefits for relapsed malignant mesothelioma, its cost-effectiveness requires further investigation.
...
-
A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme
BackgroundThis study assessed whether a relatively newly developed Parent and Infant (PIN) parenting support programme was cost-effective when...
-
Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study
BackgroundTuberculosis (TB) is a major threat to public health, particularly in countries where the disease is highly prevalent, such as Ethiopia....
-
Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression
Treatment-resistant depression (TRD) affects approximately 2.8 million people in the U.S. with estimated annual healthcare costs of $43.8 billion....
-
Cost-effectiveness of linezolid to ventilator-associated pneumonia in Colombia
IntroductionVentilator-associated pneumonia (VAP) is a prominent cause of morbidity and mortality in intensive care unit (ICU) patients. Due to the...
-
Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
IntroductionIn recent years, the role of pharmacists has undergone significant transformation to become more patient-centered and involved in...
-
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
BackgroundAfrica has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV)...
-
Cost-effectiveness analysis of typhoid vaccination in Lao PDR
BackgroundTyphoid vaccination has been shown to be an effective intervention to prevent enteric fever and is under consideration for inclusion in the...
